CIK 0000899923
- Accelerated filer
MYRIAD GENETICS INC
Sign in to watch- Ticker
- MYGN
- Exchange
- Nasdaq
- Industry
- In Vitro & In Vivo Diagnostic Substances
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 870494517
- Phone
- +1 801-584-3600
- Business address
- 322 NORTH 2200 WEST, SALT LAKE CITY, UT, 84116
- Former names
- MYRIAD GENETICS INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $34,252
- in 1 filing
Net −$34,252. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2019-09-25 | King Gary A. Exec. VP International Ops | Grant or award | +27,000 | 155,550 | ||
| 2019-09-25 | Capone Mark Christopher President & C.E.O. | Grant or award | +142,500 | 583,333 | ||
| 2019-09-25 | Capone Mark Christopher President & C.E.O. | Returned to the company | −15,800 | $29.93 | $473K | 567,533 |
| 2019-09-25 | Capone Mark Christopher President & C.E.O. | Returned to the company | −18,295 | $29.93 | $548K | 549,238 |
| 2019-09-25 | LANCHBURY JERRY S Chief Scientific Officer | Grant or award | +38,000 | 203,899 | ||
| 2019-09-25 | LANCHBURY JERRY S Chief Scientific Officer | Returned to the company | −4,214 | $29.93 | $126K | 199,685 |
| 2019-09-25 | LANCHBURY JERRY S Chief Scientific Officer | Returned to the company | −5,544 | $29.93 | $166K | 194,141 |
| 2019-08-01 | Tobin Bernard President Crescendo BioScience | Sale | −11,712 | $40.00 | $468K | 146,040 |
| 2019-08-01 | Riggsbee Richard Bryan Chief Financial Officer | Sale | −25,000 | $41.50 | $1.0M | 120,566 |
| 2019-08-01 | King Gary A. Exec. VP International Ops | Exercise or conversion | +30,000 | $26.49 | $795K | 164,871 |
| 2019-08-01 | King Gary A. Exec. VP International Ops | Sale | −30,000 | $46.19 | $1.4M | 134,871 |
| 2019-08-01 | King Gary A. Exec. VP International Ops | Exercise or conversion | +10,000 | $23.98 | $240K | 144,871 |
| 2019-08-01 | King Gary A. Exec. VP International Ops | Sale | −10,000 | $43.48 | $435K | 134,871 |
| 2019-08-01 | King Gary A. Exec. VP International Ops | Exercise or conversion | +20,000 | $19.47 | $389K | 154,871 |
| 2019-08-01 | King Gary A. Exec. VP International Ops | Sale | −20,000 | $39.44 | $789K | 134,871 |
| 2019-08-01 | King Gary A. Exec. VP International Ops | Exercise or conversion · Non-Qualified Stock Option (right to buy) | −20,000 | 7,432 | ||
| 2019-08-01 | King Gary A. Exec. VP International Ops | Exercise or conversion · Non-Qualified Stock Option (right to buy) | −10,000 | 1,830 | ||
| 2019-08-01 | King Gary A. Exec. VP International Ops | Exercise or conversion · Non-Qualified Stock Option (right to buy) | −30,000 | 106,225 | ||
| 2019-08-01 | Capone Mark Christopher President & C.E.O. | Exercise or conversion | +70,672 | $23.11 | $1.6M | 511,505 |
| 2019-08-01 | Capone Mark Christopher President & C.E.O. | Sale | −70,672 | $44.00 | $3.1M | 440,833 |
Page 36 of 60 · 1,194 trades